ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NBIX announcements Neurocrine Biosciences, Inc. announcements and dividends declared USA

Neurocrine Biosciences, Inc. Complete list of announcements declared & dividend announcements by Neurocrine Biosciences, Inc. NBIX

Neurocrine Biosciences, Inc. NBIX listed on USA and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Neurocrine Biosciences, Inc. NBIX

Bull of the Day: Neurocrine Biosciences (NBIX)
Neurocrine Biosciences (NBIX) has quietly become one of biotech's strongest earnings stories.
Announcement as on 29 June 2026

: Neurocrine Biosciences price target raised at Oppenheimer after FDA approves movement disorder treatment
Neurocrine Biosciences Inc. NBIX said Friday that the U.S. Food and Drug Administration has approved Ingrezza for treatment of an involuntary movement disorder linked with Huntington’s disease, prompting analysts at Oppenheimer to boost their price targ
Announcement as on 21 August 2023

Bear of the Day: Neurocrine Biosciences (NBIX)
Neurocrine Biosciences NBIX is an .5 billion neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders.The company's neuroscience, endocr
Announcement as on 28 February 2022

Bear of the Day: Neurocrine Biosciences (NBIX)
Neurocrine Biosciences NBIX is an .5 billion neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders.The company's neuroscience, endocr
Announcement as on 28 February 2022

Neurocrine Biosciences, Inc. Shares Near 52-Week Low - Market Mover
Neurocrine Biosciences, Inc. (NBIX) shares closed today at 0.3% above its 52 week low of .50, giving the company a market cap of B. The stock is currently down 9.3% year-to-date, down 9.0% over the past 12 months, and up
Announcement as on 30 November 2021

Announcements by Neurocrine Biosciences, Inc. first page | Next page |

NBIX Neurocrine Biosciences, Inc. current price & indicator signals

Moving Averages for Neurocrine Biosciences, Inc.

  • 5Day Average: 136.14
  • 12Day Average: 140.18
  • 20Day Average: 140.13
  • 50Day Average: 148.73
  • 100Day Average: 158.62
  • 150Day Average: 151.98
  • 200Day Average: 147.24

NBIX Indicators & signals

Indicator MACD (12,26,9)

139.11, 142.79, -3.66
Indicator MACD is in negative zone

Indicator ADX (14)

38.65, 13.19, 29.82
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 43
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NBIX Neurocrine Biosciences, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Mon Oct 2026 136.98 135.01 to 137.53 0.94% 0.79 times
16 Fri Oct 2026 135.71 135.55 to 138.20 -0.91% 0.85 times
15 Thu Oct 2026 136.95 135.55 to 138.23 0.77% 1.04 times
14 Wed Oct 2026 135.91 132.25 to 136.57 0.58% 1.14 times
13 Tue Oct 2026 135.13 134.89 to 139.93 -4.41% 1.18 times
12 Mon Oct 2026 141.37 140.89 to 143.63 -0.75% 0.82 times
09 Fri Oct 2026 142.44 140.02 to 143.55 0.84% 0.77 times
08 Thu Oct 2026 141.25 140.34 to 143.02 -1.55% 0.93 times
07 Wed Oct 2026 143.47 143.21 to 145.88 -1.4% 0.86 times
06 Tue Oct 2026 145.51 141.39 to 145.77 0.9% 1.09 times
05 Mon Oct 2026 144.21 142.48 to 146.91 0.72% 1.32 times
02 Fri Oct 2026 143.18 140.36 to 144.56 1.76% 1.24 times

Videos related to: NBIX announcements Neurocrine Biosciences, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NBIX announcements Neurocrine Biosciences, Inc. announcements and dividends declared USA

 

Back to top